Costimulation plays very important role in T cells activation and tumor immunity. B71 is alone of the major costimulatory molecules both in human and rodents. Previous work indicated that B71 gene transfected EL4 lymp...Costimulation plays very important role in T cells activation and tumor immunity. B71 is alone of the major costimulatory molecules both in human and rodents. Previous work indicated that B71 gene transfected EL4 lymphoma can induce antitumor immunity in vivo. This paper showed that inoculation of EL4B71+ plus IL2 could elicit an antitumor effects in vivo and in vitro. Immunization with EL4B71+ tumor cells or EL4B71+ tumor cells plus IL2 could significantly prolong the survival time of the EL4 tumorbearing mice and also delay the occurrence of the tumor node in vivo. A strong proliferation response and CTL activity as well as the increased IL2 and TNF production of the splenocyte from the immunized mice with EL4B71+ or EL4B71+ plus IL2 were seen in the in vitro TLMC system. These finding indicated that the costimulatory molecule is necessary for inducing an effective antitumor immunity and IL2 optimal production.展开更多
Oncolysates, debris of tumor cells, have been proven to be effective in active immunotherapy of cancer. In this experiment, the oncolysates from murine melanoma cells B16F10 transfected by recombinant vaccinia viruses...Oncolysates, debris of tumor cells, have been proven to be effective in active immunotherapy of cancer. In this experiment, the oncolysates from murine melanoma cells B16F10 transfected by recombinant vaccinia viruses encoding human IL2(IL2VBO) were used as vaccine. After treatment of tumor bearing mice with pulmonary metastases by intravenous injection of IL2VBO or rVVIL2, higher level IL2 activity was detected in the serum of IL2VBO or rVVIL2 treated mice at 8h. Further experiment results demonstrated that IL2VBO significantly reduced the number of pulmonary metastases and prolonged the survival time of tumorbearing mice when compared with other preparations. Fresh peripheral blood lymphocytes from IL2VBO treated mice showed potent cytotoxicity to B16F10 cells and YAC1 cells. But only cytotoxicity to B16F10 cells is more marked than that in rVVIL2 group, indicating that the IL2VBO could induce specific and non specific antitumor immunity. Because IL2 expression was at the same level in the serum of IL2VBO or rVVIL2 treated mice, the results suggested that the specific antitumor immunity induced by IL2VBO might contribute to the enhanced therapeutic effect of IL2VBO.展开更多
文摘Costimulation plays very important role in T cells activation and tumor immunity. B71 is alone of the major costimulatory molecules both in human and rodents. Previous work indicated that B71 gene transfected EL4 lymphoma can induce antitumor immunity in vivo. This paper showed that inoculation of EL4B71+ plus IL2 could elicit an antitumor effects in vivo and in vitro. Immunization with EL4B71+ tumor cells or EL4B71+ tumor cells plus IL2 could significantly prolong the survival time of the EL4 tumorbearing mice and also delay the occurrence of the tumor node in vivo. A strong proliferation response and CTL activity as well as the increased IL2 and TNF production of the splenocyte from the immunized mice with EL4B71+ or EL4B71+ plus IL2 were seen in the in vitro TLMC system. These finding indicated that the costimulatory molecule is necessary for inducing an effective antitumor immunity and IL2 optimal production.
文摘Oncolysates, debris of tumor cells, have been proven to be effective in active immunotherapy of cancer. In this experiment, the oncolysates from murine melanoma cells B16F10 transfected by recombinant vaccinia viruses encoding human IL2(IL2VBO) were used as vaccine. After treatment of tumor bearing mice with pulmonary metastases by intravenous injection of IL2VBO or rVVIL2, higher level IL2 activity was detected in the serum of IL2VBO or rVVIL2 treated mice at 8h. Further experiment results demonstrated that IL2VBO significantly reduced the number of pulmonary metastases and prolonged the survival time of tumorbearing mice when compared with other preparations. Fresh peripheral blood lymphocytes from IL2VBO treated mice showed potent cytotoxicity to B16F10 cells and YAC1 cells. But only cytotoxicity to B16F10 cells is more marked than that in rVVIL2 group, indicating that the IL2VBO could induce specific and non specific antitumor immunity. Because IL2 expression was at the same level in the serum of IL2VBO or rVVIL2 treated mice, the results suggested that the specific antitumor immunity induced by IL2VBO might contribute to the enhanced therapeutic effect of IL2VBO.
